Introduction
Alzheimer's disease (AD) is a fatal incurable neurodegenerative disease that is prevalent worldwide (1) . The progressive disease is characterized by the accumulation of plaques formed of short β-amyloid (Aβ) peptides, neurofibrillary tangles inside neurons, loss of neurons in the hippocampus and cerebral cortex, and widespread brain atrophy. AD is the most common form of dementia in the elderly, accounting for 50-70% of the late-onset dementia, with 17-20 million affected worldwide (2) . Although several key proteins, such as amyloid precursor protein (APP), β-secretase 1, Tau and presenillin-1 (PSEN1), have been identified to be implicated in AD pathogenesis, the etiology and pathogenesis of AD are not well understood.
MicroRNAs are a group of small (~22 nucleotides) endogenous noncoding RNAs, that function as suppressors of gene expres sion. By binding to the 3'-UTR of their target genes, miRNAs can induce mRNA degradation or translational repression (3, 4) . miRNAs are abundant in the brain and crucially important in neurodevelopment and synaptic plasticity (5, 6) . Increasing evidence has revealed that alterations in miRNA expression may contribute to the initiation and progression of AD (7) (8) (9) (10) (11) . However, the mechanism underlying the role of microRNAs in AD has not been fully elucidated. p27 Kip1 is encoded by cyclin-dependent kinase inhibitor 1B and functions to negatively control cell cycle progression (12, 13) . Expression of p27 Kip1 can normally inhibit the phosphorylation of pRb and therefore arrest cell proliferation at G1. A number of studies have shown that disordered expression of cell-cycle markers, including p27 Kip1 , contributes to the pathogenesis of AD (14, 15) . However, p27 Kip1 gene expression regulation is not completely understood. The present study hypothesized that the expression of p27 Kip1 may be regulated by certain miRNAs, and aimed to elucidate the interactions between miR-222 and p27 Kip1 in AD
Materials and methods
Animal model. The APPswe/PSΔE9 mice model was purchased from the Jackson Laboratory (Ben Harbor, ME, USA). Briefly, the transgenic mice were established by co-injection of the APPswe and PS1ΔE9 vectors (16) . The expression of the transgenes is under the control of the mouse prion protein promoter, which can drive high protein expression in the neurons and astrocytes of the central nervous system (17, 18 
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Total RNA from brains and cultured cells was isolated using the mirVanaTM miRNA Isolation kit (AM1560, Ambion, Austin, TX, USA) in accordance with the manufacturer's instructions. The RNA was treated with DNase I (AM1906, Ambion) to eliminate genomic DNA contamination. RNA (1 µg) was reverse transcribed into miRNA cDNA and total cDNA using the miScript Reverse Transcription kit (218061, Qiagen, Hilden, Germany), followed by qPCR on a Lightcycler (Roche Diagnostics, Mannheim, Germany) machine using the miScript SYBR Green PCR kit (218073, Qiagen), according to the manufacturer's instructions. Primers for mature miR-222 and U6snRNA were purchased from Qiagen (MS00007609 and MS00007497, Hilden, Germany). The primer sequence were as follows: Forward: 5'-CAGGT CTCCAAGACGACATAGA-3' and reverse: 5'-CGCCTTT TCGATTCATGTACTGC-3' for p27 Kip1 (20) ; and forward: 5'-CATGGGTGTGAACCATGAGA-3' and reverse: 5'-TGT GGTCATGAGTCCTTCCA-3' for GAPDH. All reactions were run in triplicate. Relative expression levels for p27 Kip1 mRNA and miR-222 were determined using the 2 -ΔΔCq method. Kip1 was amplified by PCR using the following primers 5'-TAAGAATATGTTTCCTTGTTTATCAGAT-3' and 5'-AATAGCTATGGAAGTTTTCTTTATTGAT-3'. The PCR products were directionally cloned downstream of the Renilla luciferase stop codon in the psiCHECKTM-2 vector (C-8021, Promega Corporation, Madison, WI, USA). The 3'-UTR of the mutant vector of p27 Kip1 was also constructed by the overlap exten sion PCR method using the following primers: 5'-CTCT AAAAGCGTTGGAGCATTATGCAATTAGG-3' and 5'-CCTAATTGCATAATGCTCCAACGCTTTTAGAG-3'. The wild-type or mutant p27 Kip1 3'-UTR psiCHECK-2 plasmid was transiently co-transfected with miR-222 expression vector or negative control vector into HEK-293T cells. Cell lysates were harvested 48 h after transfection and then firefly and Renilla luciferase was measured with the Dual Luciferase Reporter Assay system (E1910, Promega Corporation) following the manufacturer's instructions. Renilla luciferase activities were normalized to firefly luciferase activities to also control transfection efficiency.
Western blot analysis. The cells and tissues were homogenized in chilled radioimmunoprecipitation assay lysis buffer (Beyotime Institute of Biotechnology, Shanghai, China) and stood for 30 min on ice. After centrifugation at 17,530 x g for 30 min at 4˚C, the supernatants were collected as protein samples. The protein concentration was detected by the BCATM Protein Assay kit (Pierce, Biotechnology Inc., Rockford, IL, USA). Proteins (40 µg) were separated on 12% SDS-PAGE gels (Thermo Fisher Scientific, Inc., Waltham, MA, USA), and transferred to nitrocellulose membranes (Millipore, Billerica, MA, USA). The membranes were blocked with 5% non-fat milk for 2 h, and incubated overnight at 4˚C with mouse monoclonal anti-human/mouse primary antibody against p27 Kip1 (1:250; cat. no. ab82264, Abcam, Cambridge, MA, USA) and rabbit polyclonal anti-human/mouse primary antibody against GAPDH (1:500; cat. no. D261392; Sangon Biotech). The membranes were then washed in Tris-buffered saline (TBS) for three times, and incubated for 1 h at room temperature with horseradish peroxidase-conjugated goat anti-mouse/rabbit secondary antibody (1:1,000; cat. no. A0216/A0208; Beyotime Institute of Biotechnology). Subsequent to another three washes in TBS, signals from the bound secondary antibody were generated using the enhanced chemiluminescence solution (Amersham, Piscataway, NJ, USA) and were detected by exposure of the membranes to X-ray films (Kodak, Rochester, NY, USA). The relative signal intensity was quantified by densitometry with UVIPhoto and UVISoft UVIBand Application V97.04 (Uvitech, Cambridge, UK). Kip1 mRNA. p3'UTR-p27 or p3'UTRmut-p27 luciferase constructs containing a wild-type or a mutated p27 Kip1 3'UTR were cotransfected into HEK-293T cells with the miR-222 expression vector (P-222) or negative control vector. Luciferase activity was determined 48 h after transfection. The ratio of normalized sensor to control luciferase activity is shown. Error bars represent the standard deviation and were obtained from three independent experiments. * P<0.05. miR, microRNA; UTR, untranslated region.
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The differences between groups were analyzed by Student's t-test. P-values are two-sided, and P≤0.05 was considered to indicate a statistically significant difference.
Results

miR-222 is downregulated in
APPswe/PSΔE9 mice versus control mice. Eight 6-month-old transgenic mice and eight age-matched controls were used in this study. RT-qPCR was performed to evaluate the miR-222 expression level in 8 APPswe/PSΔE9 mice and 8 controls. All reactions were run in triplicate. As shown in Fig. 1A , there was a significantly decreased level of miR-222 in the APPswe/PSΔE9 mice compared with the control group. Kip1 protein in APPswe/PSΔE9 mice and control mice. To investigate the potential interaction of miR-222 and p27 Kip1 in vivo, western blot analysis was performed on the total protein extracts from the cerebral cortex of 6-month-old APPswe/PSΔE9 mice and controls. It was demonstrated that the level of p27 Kip1 protein was increased in the APPswe/PSΔE9 mice compared with age-matched controls (Fig. 1B and C) , which is inversely associated with the expression of miR-222. In addition, the mRNA level of p27 Kip1 was also detected by RT-qPCR in the same mice and no significant difference was observed (Fig. 1D) . It is well-known that miRNAs execute post-transcriptional regulation by inducing mRNA degradation or translational repression. The present data indicated that low miR-222 expression may positively regulate p27 Kip1 expression by promoting the translation of p27 Kip1 mRNA.
Reduced miR-222 is correlated with high level of p27
3'UTR of p27 Kip1 mRNA is targeted by miR-222 in HEK-293T cells. To investigate whether p27
Kip1 is a target gene of miR-222 the alignment of miR-222 with the 3'-UTR of p27 Kip1 was analyzed by the miRNA target prediction algorithm TargetScan (http://www.targetscan.org/). It was shown that there was one putative binding site in the 3'-UTR of p27 Kip1 , which has conserved binding sites for miR-222. To experimentally validate the potential interaction, a luciferase reporter con taining the 3'-UTR of human p27 Kip1 was cotransfected into HEK-293T cells with the miR-222-expression vector or negative control vector. The luciferase activity was measured 48 h post transfection. As shown in Fig. 2 , the overexpression of miR-222 produced a highly significant reduction (54%, P<0.05) in luciferease activity of the reporter plasmid compared with the controls. In addition, when the predicted binding site of miR-222 in the 3'-UTR was mutated by overlapping PCR, the repression of luciferease activity caused by miR-222 overexpression was abrogated. Collectively, the data suggest that p27
Kip1 is a predicted target of miR-222, and the inhibitory effect of miR-222 is due to direct interaction with the putative binding site of the 3'-UTR of p27 Kip1 .
miR-222 regulates p27
Kip1 expression in SH-SY5Y cells. To further determine whether miR-222 can directly regulate p27 Kip1 , the changes in the p27 Kip1 level in SH-SY5Y cells following miR-222 overexpression were analyzed. To do this, the stable transfectant cell line of miR-222, which showed a 3.5-fold increase in miR-222 levels compared with controls (Fig. 3A) , was generated. In addition, western blot analysis was performed on the same cells to evaluate the protein level of p27 Kip1 . The results showed that there was a significant 
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reduction in the p27 Kip1 protein level (86%, P<0.05) in the stable transfection cell line of miR-222, as compared with cells transfected with the control vector ( Fig. 3B and C) . Furthermore, miR-222 expression was knocked down by transfecting SH-SY5Y cells with LNA antisense oligonucleotides targeting miR-222 and the effects on p27
Kip1 production were analyzed. There was a 2.7-fold decrease of miR-222 level in SH-SY5Y cells transfected with anti-222 LNA compared with cells transfected with LNA against a microRNA not expressed in these cells (Fig. 3A) . As expected, the reduction of miR-222 was accompanied by an increase in p27
Kip1 protein of 2.1-fold ( Fig. 3B and 3C) . It is well-understood that repression of gene expression by miRNAs may be due to translational repression or mRNA degradation. To test the relative contribution of the two mechanisms, the p27
Kip1 mRNA level was detected and no significant difference was observed following overexpression or knockdown of miR-222. The data demonstrated that miR-222 may regulate p27 Kip1 expression by interfering with translation of p27 Kip1 mRNA, rather than inducing mRNA degradation.
Discussion
miRNAs are small non-coding RNA molecules, ~ 22 nucleotides in length, that regulate gene expression by repressing translation or degrading target mRNAs. miRNAs are abundantly expressed in the brain, where they regulate diverse neuronal and glial functions (4) . Numerous types of miRNAs have been recognized to be correlated with neurodegenerative diseases (21) (22) (23) . miR-222 is a member of the to the miR-221/222 family and has been identified to be overexpressed in several types of cancer (24) (25) (26) (27) . Growing evidence has indicated the important roles of miR-222 in tumor proliferation, drug resistance, apoptosis and metastasis (28) (29) (30) . However, for miR-222, the possible roles and associated target genes in AD is unclear. In the current study, it was observed that miR-222 is downregulated in APPswe/PSΔE9 mice compared with age-matched controls. In addition, the overexpression of miR-222 or its knockdown produced the predictable opposite effects on p27 Kip1 expression. Through the luciferase assay, it was demonstrated that miR-222 can directly target p27 Kip1 by interaction with the putative binding site of the 3'-UTR of p27 Kip1 . Previous studies have reported that the dysregulation of cell-cycle markers is important in AD pathogenesis (31) (32) (33) (34) (35) (36) (37) (38) (39) . p27 Kip1 , also termed cyclin-dependent kinase inhibitor 1B, can prevent cell-cycle progression from the G1 to S phase by binding to CDK2 and cyclin E complexes. Extensive evidence has suggested that the overexpression of p27 Kip1 is correlated with the pathogenesis of AD. However, p27
Kip1 gene expression regulation is not completely understood. The present study analyzed the expression of p27 Kip1 in the cerebral cortex of APPswe/PSΔE9 mice and demonstrated that the protein level of p27 Kip1 is upregulated in these mice compared with age-matched controls. However, there was no significant difference in mRNA level of p27 Kip1 between the model mice and controls. This indicates that p27 Kip1 mRNA may be regulated through a post-transcriptional mechanism. Sequence analysis by Targetscan suggested that the 3'-UTR of p27 Kip1 mRNA contained a predicted binding site for miR-222. An inverse correlation between the expression of miR-222 and p27 Kip1 was identified in the model mice and controls. Additionally, there was an inverse correlation between the p27 Kip1 and miR-222 expression levels in SH-SY5Y cells. Collectively, the results indicated that p27
Kip1 is a direct target of miR-222 and the downregulation of miR-222 may contribute to the dysregulation of the cell cycle in AD due to dysregulation of the expression of p27 Kip1 .
In conclusion, it was confirmed that miR-222 was downregulated in AD, in association with p27 Kip1 upregulation. miR-222 can directly target p27
Kip1 by binding to the 3'-UTR of p27 Kip1 inducing the translational repression of p27 Kip1 . Therefore, downregulation of miR-222 may be correlated with the dysregulation of the cell cycle in AD by affecting the expression of p27 Kip1 .
